文献速递血液净化与透析

无醋酸盐枸橼酸酸化碳酸氢盐透析改善血清钙化倾向的初步研究

Acetate-free, citrate-acidified bicarbonate dialysis improves serum calcification propensity-a preliminary study.
PubMed 文献 · Nephrol Dial Transplant · 2018-01-01

该初步研究在78例欧洲维持性血液透析患者中,评估转为无醋酸盐枸橼酸酸化标准碳酸氢盐透析(CiaHD)3个月对血清钙化倾向(T50试验)的影响。结果显示CiaHD期间T50显著升高(206±56至242±56 min,P<0.001),转回醋酸盐后无显著变化(P=0.29)。CiaHD、血清磷酸盐变化和白蛋白变化是T50变化的 strongest 决定因素。

要点

  • CiaHD透析3个月可显著提高血清钙化抵抗(T50延长)。
  • 转回醋酸盐透析后T50无显著改善。
  • CiaHD对T50的影响独立于离子钙和镁的变化。

核心结论

  • CiaHD透析可改善T50试验所测的钙化倾向,但能否持续转化为抗钙化血清环境需进一步研究。

研究设计与样本

  • 初步研究,纳入78例欧洲维持性血液透析患者,配对收集CiaHD前及3个月后周中透析前血清,其中44例随后转回醋酸盐透析。

主要发现

  • CiaHD 3个月后T50从206±56 min显著升至242±56 min(P<0.001)。
  • 转回醋酸盐后T50从252±63 min降至243±64 min(n=44,P=0.29),无统计学意义。
  • CiaHD、Δ血清磷酸盐和Δ白蛋白是T50变化的最强决定因素,Δ离子钙和Δ镁不是。
  • CiaHD 3个月期间仅血清白蛋白显著变化,磷酸盐未显著变化。

临床怎么用

  • 对于维持性血液透析患者,可考虑使用无醋酸盐枸橼酸酸化碳酸氢盐透析以改善钙化倾向,但需进一步研究确认临床获益。

局限性

  • 为初步研究,样本量有限(78例,转回组44例),需更大规模研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A novel in vitro test (T50 test) assesses ex vivo serum calcification propensity and predicts mortality in chronic kidney disease and haemodialysis (HD) patients. For the latter, a time-dependent decline of T50 was shown to relate to mortality. Here we assessed whether a 3-month switch to acetate-free, citrate-acidified, standard bicarbonate HD (CiaHD) sustainably improves calcification propensity. METHODS: T50 values were assessed in paired midweek pre-dialysis sera collected before and 3 months after CiaHD in 78 prevalent European HD patients. In all, 44 were then switched back to acetate. Partial correlation was used to study associations of changing T50 and changing covariates. Linear mixed effect models were built to assess the association of CiaHD and covariates with changing T50. RESULTS: A significant intra-individual increase of serum calcification resilience was found after 3 months on CiaHD (206 ± 56 to 242 ± 56 min; P < 0.001), but not after switching back to acetate (252 ± 63 to 243 ± 64 min; n = 44; P = 0.29). CiaHD, Δ serum phosphate and Δ albumin but not Δ ionized calcium and magnesium were the strongest determinants of changing T50. Beneath T50, only serum albumin but not phosphate changed significantly during 3 months of CiaHD. CONCLUSION: CiaHD dialysis favourably affected calcification propensity as measured by the T50 test. Whether this treatment, beyond established phosphate-directed treatments, has the potential to sustainably tip the balance towards a more anti-calcific serum milieu needs to be further investigated.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Lorenz G, Mayer CC, Bachmann Q, et al. Acetate-free, citrate-acidified bicarbonate dialysis improves serum calcification propensity-a preliminary study. Nephrol Dial Transplant. 2018. PMID: 29860419. doi:10.1093/ndt/gfy134

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。